Danaher earnings boost other diagnostics, life sciences support companies
JHVEPhoto         

Diagnostics companies and others that support the life sciences industry are higher in Thursday afternoon trading following Danaher's (NYSE:DHR) Q2 2022 top and bottom lines beat.
Danaher (DHR) isÂ up 8%. Thermo Fisher Scientific (NYSE:TMO) andÂ Agilent (NYSE:A) are bothÂ up 6%, Bio-Rad Laboratories (BIO)Â +7%,Â Mettler-Toledo (MTD)Â +5%, and Illumina (NASDAQ:ILMN)Â +2.5%.
Thermo Fisher (TMO) and Bio-Rad (BIO) are the next to report earnings, both on July 28.
See why Stock Metal Investment says both Danaher (DHR) and Thermo Fisher (TMO) are buys.